Brimonidine Tartrate ophthalmic solution, 0.15%

FDA Drug Profile — Brimonidine Tartrate ophthalmic solution, 0.15%

Brimonidine Tartrate ophthalmic solution, 0.15% is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Brimonidine Tartrate ophthalmic solution, 0.15%. Available dosage form: solution/ drops.

Drug details

Generic Name
Brimonidine Tartrate ophthalmic solution, 0.15%
Brand Names
Brimonidine Tartrate ophthalmic solution, 0.15%
Application Number
ANDA215225
Sponsor
Alembic Pharmaceuticals Limited
NDC Codes
2
Dosage Forms
SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients
BRIMONIDINE TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE Brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.